JRJ
AMBI

Jeffrey R. Jay’s Ambit Biosciences Corp AMBI Stock Holding History

Jeffrey R. Jay’s Portfolio AMBI Stock Details AMBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$7M Buy
+1,000,000
New +$7.15M 5.53% 5

Other funds holding AMBI

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PRCM
Pine River Capital Management Minnetonka, Minnesota $32.9M AUM 4.47% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FM
Forward Management San Francisco, California $907M AUM 0.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jeffrey R. Jay's AMBI Position: Q2 2013 in Review

Jeffrey R. Jay opened a new position in Ambit Biosciences Corp (AMBI) in Q2 2013: 1,000,000 shares worth $7M. The stake represents 5.53% of the portfolio and ranks #5 among its holdings.

15 funds tracked by Wall St. Rank hold AMBI as of Q2 2013.

  • Jeffrey R. Jay held 1,000,000 shares of Ambit Biosciences Corp worth $7M as of Q2 2013.
  • Ambit Biosciences Corp was a new Jeffrey R. Jay position in Q2 2013.
  • Ambit Biosciences Corp made up 5.53% of Jeffrey R. Jay's portfolio in Q2 2013, its #5 holding.
  • 15 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q2 2013.

Based on Jeffrey R. Jay's 13F filing for Q2 2013, filed 14 Aug 2013.